Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
European Archives of Psychiatry and Clinical Neuroscience
Published in: European Archives of Psychiatry and Clinical Neuroscience 4/2017

01-06-2017 | Letter to the Editor

A trans-diagnostic approach to psychosis, psychiatric medication nomenclature and stigma

Authors: Marina Economou, Helen Lazaratou

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 4/2017

Login to get access

Excerpt

Recent scientific advances stimulate thinking on the boundaries between normal and abnormal behaviour and the importance—both clinical and ethical—of the diagnoses we assign to people whose symptoms exceed a given threshold. In essence, psychosis is currently conceptualized as an (extended) continuous phenotype, which encompasses subclinical psychotic-like experiences in the general population [1]. Therefore a dimensional classification of mental disorders, in the context of a trans-diagnostic approach is substantiated. We cannot help but wonder how this new conceptualization may influence clinical practice, and especially with regard to the stigma attached to mental illness. …
Literature
1.
van Os J, Reininghaus U. Psychosis as a transdiagnostic and extended phenotype in the general population (2016). World Psychiatry 15:118–124.
2.
Schulze B, Angermeyer MC (2003) Subjective experiences of stigma. A focus group study of schizophrenic patients, their relatives and mental health professionals. Soc Sci Med 56:299–312CrossRefPubMed
3.
Corrigan P, Watson AC (2002) Understanding the impact of stigma on people with mental illness. World Psychiatry 1:16–20
4.
Lee S, Chin MY, Tsang A, Chui H, Kleinman A (2006) Stigmatizing experience and structural discrimination associated with the treatment of schizophrenia in Honk Kong. Soc Sci Med 62:1685–1696CrossRefPubMed
5.
Hudson TJ, Thrush CR, Han X, Pyne JM, Thapa P, Sullivan G (2004) A pilot study of barriers to medication adherence in schizophrenia. J Clin Psychiatry 65:211–216CrossRefPubMed
6.
Sajatovic M, Jenkins JH (2007) Is antipsychotic medication stigmatizing for people with mental illness? Int Rev Psychiatry 19:107–112CrossRefPubMed
7.
Highet NJ, McNair BG, Thompson M, Davenport TA, Hickie IB (2004) Experience with treatment services for people with bipolar disorder. Med J Australia 181:S47–S51
8.
Sato M (2006) Renaming schizophrenia: a Japanese perspective. World Psychiatry 5:53–55
9.
10.
Fiorillo A, Luciano M, Del VEcchio V, Sampogna G, Obradors-Tarrago C, Maj M, ROMAER Consortium (2013) Priorities for mental health research in Europe: a survey among national stakeholders’ associations within the ROAMER project. World Psychiatry 12:165–170
11.
Thornicroft G (2006) Shunned: Discrimination against people with mental illness. Oxford University Press, Oxford
Metadata
Title
A trans-diagnostic approach to psychosis, psychiatric medication nomenclature and stigma
Authors
Marina Economou
Helen Lazaratou
Publication date
01-06-2017
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue 4/2017
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-016-0763-9

Other articles of this Issue 4/2017

European Archives of Psychiatry and Clinical Neuroscience 4/2017 Go to the issue

Original Paper

Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies

Short Communication

Self-stigma and suicidality: a longitudinal study

Original Paper

Clinical response in a risperidone-medicated naturalistic sample: patients’ characteristics and dose-dependent pharmacokinetic patterns

Original Paper

Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP)

Original Paper

The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis

Original Paper

The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study